Konferenzen  >  Medizin & Gesundheitswesen  >  Translationale Medizin, Klinische Studien  >  Frankreich

ESMO - European Society for Medical Oncology

MAP is the leading congress in precision oncology, designed to provide the latest breaking data in the field of molecular profiling and personalised medicine. The focus of the event is to create a bridge between basic scientists, or people working on new technologies, and medical doctors and healthcare providers. Our globally recognised experts in clinical and precision oncology will welcome delegates for three days of discussions on the latest discoveries in precision medicine, cancer-stromal interactions, clonal evolution, metastatic dissemination and drug response and resistance.

The MAP Congress is the result of a solid partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, all committed to offering the best care to people with cancer worldwide, through oncology education and research.

MAP Congress Team;     Tel.: [+41919731947];     Email: map@esmo.org

oncology, personalised medicine, precision medicine, translational research, molecular characterisation, clonal evolution, cancer profiling, metastatic dissemination, biomarkers, targeted therapeutics

Onkologie,    Pharmakogenomik, Personalisierte Medizin